1-Hydroxybenzotriazole → HCID 59784110, compound
Reaction equation
[C@H:1]1([NH:11][C:12]([C@H:14]2[NH:19][CH2:18][CH2:17][N:16]([C:20]([O:22][CH2:23][C:24]3[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=3)=[O:21])[CH2:15]2)=[O:13])[C:10]2[C:5](=[CH:6][CH:7]=[CH:8][CH:9]=2)[CH2:4][CH2:3][CH2:2]1.[C:30]([NH:37][C@H:38]([C:42](O)=[O:43])[CH:39]([CH3:41])[CH3:40])([O:32][C:33]([CH3:36])([CH3:35])[CH3:34])=[O:31].CCN(C(C)C)C(C)C.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.C1C=CC2N(O)N=NC=2C=1>CN(C=O)C>[C:33]([O:32][C:30]([NH:37][C@@H:38]([CH:39]([CH3:41])[CH3:40])[C:42]([N:19]1[CH2:18][CH2:17][N:16]([C:20]([O:22][CH2:23][C:24]2[CH:25]=[CH:26][CH:27]=[CH:28][CH:29]=2)=[O:21])[CH2:15][C@H:14]1[C:12]([NH:11][C@H:1]1[C:10]2[C:5](=[CH:6][CH:7]=[CH:8][CH:9]=2)[CH2:4][CH2:3][CH2:2]1)=[O:13])=[O:43])=[O:31])([CH3:36])([CH3:35])[CH3:34]Participants
7
Reactant 5
Product 1
Reagents, catalysts & solvents 1
Procedure
The deprotected piperazine 3 (16.20 g, 41.2 mmol) is coupled with BOC-L-valine (8.95 g, 41.2 mmol) using DIEA (36.0 mL, 0.21 mol), HBTU (17.19 g, 45.3 mmol) and HOBt (6.12 g, 45.3 mmol) in DMF (700 mL) under the same conditions as in step 1 above. Purification is carried out by flash chromatography on silica gel (CH2Cl2 as eluent initially, followed by 10% Et2O/CH2Cl2 to elute the desired product). The desired coupled product 4 is isolated as a white foam (15.51 g, 64% yield): 1H NMR δ (CDCl3) 6.99-7.64 (m, 9H), 5.99-6.34 (br m, 1H), 2.68-5.26 (br m, 11H), 1.51-2.15 (br m, 6H), 1.42 (s, 9H), 1.15 (s, 3H), 0.64-1.02 (br m, 5H); LCMS (APCl+) 594.2 (MH+), 537.9 (MH+-tBu), 493.7 (MH+-BOC, 100%).
Workup
- customPurification
- washto elute the desired product)
Sources & evidence
- ORD record
- ord-eb9f8e8e05a4414e899a4b13f3f4887e
- Source dataset
- uspto-grants-2011_04
- Patent number
- US07932255B2
Reaction notes
Loading…